An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

Immunity

Volumn 3, Issue 4, 1995, Pages 397-405

  Nicholson, Lindsay B ^a   Greer, Judith M ^a   Sobel, Raymond A ^b   Lees, Marjorie B ^a   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN; PROTEOLIPID PROTEIN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMAL; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; IMMUNOTHERAPY, ADOPTIVE; LIGANDS; MICE; MYELIN PROTEOLIPID PROTEIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0028866978     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-7613(95)90169-8     Document Type: Article

References (52)

1. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma
2. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major
3. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of cells
4. Regulatory T cell clones induced byoral tolerance: suppression of autoimmune encephalomyelitis
5. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
6. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand
7. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands
8. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis
9. Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-A°
10. + T cells through IL-12 produced by listeria-induced macrophages
11. Immunotherapy by peptides?
12. Signals and signs for lymphocyte responses
13. + T cells: specificity and function
14. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptorassociated determinants on effector cells by interleukin-4 secretion
15. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
16. Oral tolerance to myelin basic protein and natural recovery from experimental allergic autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-p, interleukin 4 and prostaglandin E expression in the brain
17. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein
18. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis
19. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR Vβ 8.2 transgenic mice
20. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire
21. B7-1 and B7-2 costimulatory molecules activate differentially the Thl/ Th2 developmental pathways: application to autoimmune disease therapy
22. s molecules
23. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists
24. Memories are made of this?
25. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10. PL mice
26. The immunopathogenesis and regulation of T cell-mediated demyelinating diseases
27. Cytokine patterns during the progression to AIDS
28. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties
29. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype
30. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell
31. Lymphocyte responses and cytokines
32. Altered peptide ligands can control CD4T lymphocyte differentiation in vivo
33. Cytokine regulation of T-cell function: potential for therapeutic intervention
34. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligandrelated differences in T cell receptor-dependent intracellular signaling
35. Cytokine induced immune deviation as a therapy for inflammatory autoimmune disease
36. T-cell cytokine responses in Leishmaniasis
37. Lymphokine production by human T cells in disease states
38. Cure of murine leishmaniasis with antiinterleukin 4 monoclonal antibody
39. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins
40. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
41. Antigen analogs/MHC complexes as specific T cell receptor antagonists
42. Induction of T-cell energy by altered T-cell receptor ligand on live antigenpresenting cells
43. Partial T cell signaling: altered phospho-zeta and lack of ZAP-70 recruitment in APL-induced T cell energy
44. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis
45. Autoimmune responses to myelin proteolipid protein
46. Functional diversity of T lymphocytes due to secretion of different cytokine patterns
47. Polarized patterns of cytokine secretion
48. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone
49. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide
50. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand
51. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy
52. The T lymphocyte in experimental allergic encephalomyelitis